Dr Agarwals Health IPO subscription starts on 29 January 2025 and will close on 31 January 2025. The company plans to raise around INR 2,891.57 – 3,027.26 crore via the IPO. The price band is fixed at INR 382 – 402 per share. Dr Agarwals Health Care’s IPO market lot has 35 shares, and the minimum application amount is INR 14,070. The retail quota is 35%, QIB is 50%, and NII is 15%.
Check Dr Agarwals Health IPO Subscription Status here. The subscription figures are taken from BSE and NSE and are updated at regular intervals. Here you can find Dr Agarwals Health IPO Subscription Status segregated by days and investor categories.
Dr Agarwals Health IPO Subscription Status – Live Updates
Shares allotted to anchor investors are not included in these calculations. Similarly, shares allotted to market makers, if any, are not part of these calculations.
Read Also: Best Hotel Stocks in India for 2025
Dr Agarwals Health Care – Business Background
Dr. Agarwal’s Health Care offers a wide array of eye care services, which include cataract and refractive surgeries, consultations, diagnoses, and non-surgical treatments. Additionally, they provide optical products, contact lenses, accessories, and pharmaceutical items related to eye care.
Dr. Agarwal’s Health holds the largest market share—approximately 25% of the organized eye care services market in India FY 2024. As of 30 September 2024, Dr Agarwal operates 209 facilities, including 193 in India and 16 internationally. These facilities are distributed across 117 cities in 14 Indian states, four union territories, and nine African countries. This extensive presence ensures accessibility and brand visibility in both metro and non-metro regions.
Revenue from operations grew to INR 1,332.15 crore in FY 2024, reflecting a 30.86% increase from INR 1,017.98 crore in FY 2023. EBITDA surged to INR 406.55 crore in FY 2024, with a CAGR of over 42% from FY 2022 to FY 2024. Operating profit margins also improved, with EBITDA for H1 FY 2025 reaching INR 228.47 crore, up 28.13% from H1 FY 2024. The company’s asset-light hub-and-spoke model supports its rapid expansion with minimal upfront investment, driving efficiencies and improving profitability.
Read Also: Denta Water and Infra IPO Allotment
Investor Categories in Dr Agarwals Health IPO Subscription
The three most important categories of IPO investors defined by SEBI are part of Dr Agarwals Health IPO.
Qualified Institutional Buyers (QIB) – Examples of QIBs are Foreign Portfolio Investors (FPIs), Scheduled Commercial Banks, Mutual Funds, Venture Capital Funds, Foreign Venture Capital Investors (FVCIs), Alternative Investment Funds (AIFs), Insurance Companies, Provident Funds and Pension Funds with a minimum corpus of INR 250 million.
Generally, 50% of the offer is reserved for QIBs. Some of these are classified as anchor investors which work towards stabilizing an IPO.
Non-Institutional Investor (NII) – These are affluent investors who can invest more than INR 200,000. In other words, these are High Networth Individuals (HNIs). Generally, 15% of the offer is reserved for this category. Bids in the category need to exceed INR 200,000. Typical examples include Category III FPIs, resident Indian individuals, HUFs (in the name of Karta), companies, corporate bodies, eligible NRIs, scientific institutions, societies, and trusts.
The NII category is further divided into two – big and small – the threshold application amount being INR 10,00,000 (INR 10 lakh).
Retail Individual Investor (RII) – This category is purely meant for small investors, whose bid must not exceed INR 200,000 per person. Usually, 35% of total shares are reserved for this category in the case of a company with profitable operations. If the IPO-bound company does not fulfill this criterion, only 10% of shares are reserved for retail investors.
Employee – Shares reserved for company employees are not part of the Net Offer and there may additionally be a discount on offer price to encourage employees to subscribe. Investors in the employee category may also apply under the retail category in an IPO. Therefore, this category of IPO investors has a unique advantage.
Read Also: Best Fertilizer Stocks in India
Dr Agarwals Health IPO Subscription Status FAQs
When will the Dr Agarwals Health IPO subscription start?
Dr Agarwals Health IPO subscription starts on 29 January 2025 and ends on 31 January 2025.
How to subscribe to Dr Agarwals Health IPO?
You can subscribe to the IPO through ASBA and non-ASBA options. To use ASBA, login to your bank account and apply for the IPO online. Alternatively, you can download the form online or obtain a physical form, then submit the completed form to your broker or bank.
When will Dr Agarwals Health IPO be listed?
Dr Agarwals Health IPO will be listed on 5 February 2025, on the BSE and NSE stock exchanges.
